Therapeutic Note(s)

Government of Ontario Logo
Treatment of Type 2 diabetes in patients on maximal doses of metformin (2000mg/day)who have: . Inadequate glycemic control (defined as HbA1c greater than 0.07) and intolerance or contraindication to a sulfonylurea; or . Inadequate glycemic control (HbA1c greater than 0.07) and on maximal doses of a sulfonylurea and for whom insulin is not an option.